Reuters logo
MS drug sales drive Questcor profit
July 24, 2014 / 1:30 PM / 3 years ago

MS drug sales drive Questcor profit

July 24 (Reuters) - Questcor Pharmaceuticals Inc posted a 39.5 percent rise in quarterly profit, helped by strong sales of multiple sclerosis drug Acthar.

The company’s net income rose to $96.4 million, or $1.54 per share, in the second quarter ended June 30, from $69.1 million, or $1.12 per share, a year earlier.

Revenue jumped 51 percent to $278.8 million. Acthar sales rose 48 percent to $261.4 million. (Reporting by Anand Basu in Bangalore; Editing by Saumyadeb Chakrabarty)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below